{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:23:35Z","timestamp":1792441415145,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005378","name":"Hacettepe \u00dcniversitesi","doi-asserted-by":"publisher","award":["#TTU-2023-20497"],"award-info":[{"award-number":["#TTU-2023-20497"]}],"id":[{"id":"10.13039\/501100005378","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Polycystic ovary syndrome (PCOS) is characterized by insulin resistance and metabolic dysfunction. Mitochondrial-derived peptides (MDPs), including MOTS-c, regulate glucose homeostasis and skeletal muscle metabolism. Whether MOTS-c expression is altered in PCOS across different physiological compartments remains unknown. The aim was to assess circulating and skeletal muscle MOTS-c levels in women with PCOS and to examine their associations with metabolic and hormonal parameters. Forty women with PCOS and 40 age- and BMI-matched healthy controls underwent clinical, biochemical, and hormonal phenotyping. Serum MOTS-c concentrations were quantified by ELISA. In a representative subgroup, skeletal muscle MOTS-c expression was assessed in vastus lateralis biopsy specimens using Western blotting. Women with PCOS exhibited lower circulating MOTS-c concentrations compared with controls (220.2\u2009\u00b1\u2009147.6 pg\/mL vs. 498.3\u2009\u00b1\u2009224.4 pg\/mL,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). Skeletal muscle MOTS-c expression was also reduced in the PCOS group (74.2\u2009\u00b1\u200915.2 vs. 100.0\u2009\u00b1\u20098.5 arbitrary units;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.005). Serum MOTS-c levels were inversely associated with total testosterone (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u2009\u2212\u20090.224,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.046) and total cholesterol (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u2009\u2212\u20090.228,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.044). Women with PCOS display reduced MOTS-c expression in both the circulation and skeletal muscle, suggesting reduced availability of this mitochondrial-derived peptide. Associations with hyperandrogenism and lipid profiles suggest a potential link between altered mitochondrial peptide biology and the endocrine\u2013metabolic phenotype of PCOS. These findings suggest that MOTS-c may represent a potential marker of tissue-specific mitochondrial involvement in PCOS and warrant further investigation.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-39687-x","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T18:34:38Z","timestamp":1770921278000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reduced serum and skeletal muscle MOTS c levels in women with polycystic ovary syndrome are associated with mitochondrial dysfunction"],"prefix":"10.1038","volume":"16","author":[{"given":"Irem Sonmezoglu","family":"Kutuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senay","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haydar","family":"Demirel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezcan","family":"Mumusoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turkmen","family":"Ciftci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1797-7662","authenticated-orcid":false,"given":"Bulent Okan","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"39687_CR1","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz, R. et al. Polycystic ovary syndrome. Nat. Rev. Dis. Primers. 2, 16057 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"12","key":"39687_CR2","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E. & Yildiz, B. O. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. 31 (12), 2841\u20132855 (2016).","journal-title":"Hum. Reprod."},{"issue":"1","key":"39687_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"ESHREASRM Rotterdam","year":"2004","unstructured":"Rotterdam, E. S. H. R. E. A. S. R. M., Sponsored & PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81 (1), 19\u201325 (2004).","journal-title":"Fertil. Steril."},{"issue":"5","key":"39687_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","volume":"36","author":"DA Dumesic","year":"2015","unstructured":"Dumesic, D. A. et al. Scientific statement on the diagnostic Criteria, Epidemiology, Pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr. Rev. 36 (5), 487\u2013525 (2015).","journal-title":"Endocr. Rev."},{"issue":"4","key":"39687_CR5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41574-024-01057-w","volume":"21","author":"N Helvaci","year":"2025","unstructured":"Helvaci, N. & Yildiz, B. O. Polycystic ovary syndrome as a metabolic disease. Nat. Rev. Endocrinol. 21 (4), 230\u2013244 (2025).","journal-title":"Nat. Rev. Endocrinol."},{"key":"39687_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.mito.2020.02.006","volume":"52","author":"P Shukla","year":"2020","unstructured":"Shukla, P. & Mukherjee, S. Mitochondrial dysfunction: an emerging link in the pathophysiology of polycystic ovary syndrome. Mitochondrion 52, 24\u201339 (2020).","journal-title":"Mitochondrion"},{"issue":"3","key":"39687_CR7","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cmet.2015.02.009","volume":"21","author":"C Lee","year":"2015","unstructured":"Lee, C. et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell. Metab. 21 (3), 443\u2013454 (2015).","journal-title":"Cell. Metab."},{"issue":"1","key":"39687_CR8","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41467-020-20790-0","volume":"12","author":"JC Reynolds","year":"2021","unstructured":"Reynolds, J. C. et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat. Commun. 12 (1), 470 (2021).","journal-title":"Nat. Commun."},{"key":"39687_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3389\/fendo.2019.00331","volume":"10","author":"M Ramanjaneya","year":"2019","unstructured":"Ramanjaneya, M. et al. Mitochondrial-Derived peptides are down regulated in diabetes subjects. Front. Endocrinol. (Lausanne). 10, 331 (2019).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"39687_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13098-024-01405-w","volume":"16","author":"Q Zhou","year":"2024","unstructured":"Zhou, Q. et al. The correlation between mitochondrial derived peptide (MDP) and metabolic states: a systematic review and meta-analysis. Diabetol. Metab. Syndr. 16 (1), 200 (2024).","journal-title":"Diabetol. Metab. Syndr."},{"key":"39687_CR11","doi-asserted-by":"crossref","unstructured":"Kutuk, I. S. et al. Assessment of mitochondrial peptide humanin in women with polycystic ovary syndrome: serum and skeletal muscle profile. J. Endocrinol. Invest. (2025).","DOI":"10.1007\/s40618-025-02747-6"},{"issue":"4","key":"39687_CR12","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","volume":"120","author":"HJ Teede","year":"2023","unstructured":"Teede, H. J. et al. Recommendations from the 2023 international Evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil. Steril. 120 (4), 767\u2013793 (2023).","journal-title":"Fertil. Steril."},{"issue":"10","key":"39687_CR13","doi-asserted-by":"publisher","first-page":"e3503","DOI":"10.1210\/clinem\/dgaf226","volume":"110","author":"R Azziz","year":"2025","unstructured":"Azziz, R. et al. Approach to the patient: hirsutism. J. Clin. Endocrinol. Metab. 110 (10), e3503\u2013e19 (2025).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"39687_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/humupd\/dmp024","volume":"16","author":"BO Yildiz","year":"2010","unstructured":"Yildiz, B. O., Bolour, S., Woods, K., Moore, A. & Azziz, R. Visually scoring hirsutism. Hum. Reprod. Update. 16 (1), 51\u201364 (2010).","journal-title":"Hum. Reprod. Update"},{"issue":"7","key":"39687_CR15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3109\/00365517509095787","volume":"35","author":"J Bergstrom","year":"1975","unstructured":"Bergstrom, J. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand. J. Clin. Lab. Invest. 35 (7), 609\u2013616 (1975).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"39687_CR16","doi-asserted-by":"publisher","first-page":"107982","DOI":"10.1016\/j.maturitas.2024.107982","volume":"185","author":"B Celik Eroglu","year":"2024","unstructured":"Celik Eroglu, B., Karacoban, L., Idilman, I. S., Korkusuz, F. & Yildiz, B. O. Evaluation of muscle and bone composition and function in aging women with polycystic ovary syndrome. Maturitas 185, 107982 (2024).","journal-title":"Maturitas"},{"issue":"7","key":"39687_CR17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/09513590.2017.1295440","volume":"33","author":"B Ozgen Saydam","year":"2017","unstructured":"Ozgen Saydam, B., Has, A. C., Bozdag, G., Oguz, K. K. & Yildiz, B. O. Structural imaging of the brain reveals decreased total brain and total Gray matter volumes in obese but not in lean women with polycystic ovary syndrome compared to body mass index-matched counterparts. Gynecol. Endocrinol. 33 (7), 519\u2013523 (2017).","journal-title":"Gynecol. Endocrinol."},{"issue":"1","key":"39687_CR18","doi-asserted-by":"publisher","first-page":"19781","DOI":"10.1038\/s41598-023-47073-0","volume":"13","author":"M Tang","year":"2023","unstructured":"Tang, M. et al. The role of MOTS-c-mediated antioxidant defense in aerobic exercise alleviating diabetic myocardial injury. Sci. Rep. 13 (1), 19781 (2023).","journal-title":"Sci. Rep."},{"issue":"1","key":"39687_CR19","doi-asserted-by":"publisher","first-page":"20077","DOI":"10.1038\/s41598-021-99568-3","volume":"11","author":"J Yuan","year":"2021","unstructured":"Yuan, J. et al. The mitochondrial signaling peptide MOTS-c improves myocardial performance during exercise training in rats. Sci. Rep. 11 (1), 20077 (2021).","journal-title":"Sci. Rep."},{"issue":"2","key":"39687_CR20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/cen.14007","volume":"91","author":"M Ramanjaneya","year":"2019","unstructured":"Ramanjaneya, M. et al. Lipids and insulin regulate mitochondrial-derived peptide (MOTS-c) in PCOS and healthy subjects. Clin. Endocrinol. (Oxf). 91 (2), 278\u2013287 (2019).","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"39687_CR21","doi-asserted-by":"publisher","first-page":"105987","DOI":"10.1016\/j.phrs.2021.105987","volume":"175","author":"Y Yin","year":"2022","unstructured":"Yin, Y. et al. The mitochondrial-derived peptide MOTS-c relieves hyperglycemia and insulin resistance in gestational diabetes mellitus. Pharmacol. Res. 175, 105987 (2022).","journal-title":"Pharmacol. Res."},{"key":"39687_CR22","doi-asserted-by":"publisher","first-page":"124009","DOI":"10.1016\/j.lfs.2025.124009","volume":"382","author":"T Fang","year":"2025","unstructured":"Fang, T., Han, J. C., Taberner, A. & Pham, T. MOTS-c in type 2 diabetes mellitus: from risk factors to cardiac complications and potential treatment. Life Sci. 382, 124009 (2025).","journal-title":"Life Sci."},{"issue":"8","key":"39687_CR23","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1038\/s12276-025-01521-1","volume":"57","author":"BS Kong","year":"2025","unstructured":"Kong, B. S., Lee, H., L\u2019Yi, S., Hong, S. & Cho, Y. M. Mitochondrial-encoded peptide MOTS-c prevents pancreatic islet cell senescence to delay diabetes. Exp. Mol. Med. 57 (8), 1861\u20131877 (2025).","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"39687_CR24","doi-asserted-by":"publisher","first-page":"166126","DOI":"10.1016\/j.bbadis.2021.166126","volume":"1867","author":"B Yang","year":"2021","unstructured":"Yang, B. et al. MOTS-c interacts synergistically with exercise intervention to regulate PGC-1alpha expression, attenuate insulin resistance and enhance glucose metabolism in mice via AMPK signaling pathway. Biochim. Biophys. Acta Mol. Basis Dis. 1867 (6), 166126 (2021).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"39687_CR25","doi-asserted-by":"publisher","first-page":"1120533","DOI":"10.3389\/fendo.2023.1120533","volume":"14","author":"Y Zheng","year":"2023","unstructured":"Zheng, Y., Wei, Z. & Wang, T. MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation. Front. Endocrinol. (Lausanne). 14, 1120533 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"39687_CR26","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1152\/japplphysiol.00706.2019","volume":"131","author":"F von Walden","year":"2021","unstructured":"von Walden, F. et al. Acute endurance exercise stimulates Circulating levels of mitochondrial-derived peptides in humans. J. Appl. Physiol. (1985). 131 (3), 1035\u20131042 (2021).","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"1","key":"39687_CR27","doi-asserted-by":"publisher","first-page":"130022","DOI":"10.1016\/j.bbagen.2021.130022","volume":"1866","author":"S Wijenayake","year":"2022","unstructured":"Wijenayake, S. & Storey, K. B. The role of humanin in natural stress tolerance: an underexplored therapeutic avenue. Biochim. Biophys. Acta Gen. Subj. 1866 (1), 130022 (2022).","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"11","key":"39687_CR28","doi-asserted-by":"publisher","first-page":"111212","DOI":"10.1016\/j.isci.2024.111212","volume":"27","author":"H Kumagai","year":"2024","unstructured":"Kumagai, H. et al. MOTS-c modulates skeletal muscle function by directly binding and activating CK2. iScience 27 (11), 111212 (2024).","journal-title":"iScience"},{"issue":"12","key":"39687_CR29","doi-asserted-by":"publisher","first-page":"130011","DOI":"10.1016\/j.bbagen.2021.130011","volume":"1865","author":"JST Woodhead","year":"2021","unstructured":"Woodhead, J. S. T. & Merry, T. L. Mitochondrial-derived peptides and exercise. Biochim. Biophys. Acta Gen. Subj. 1865 (12), 130011 (2021).","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"12","key":"39687_CR30","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1007\/s00125-020-05269-3","volume":"63","author":"Q Guo","year":"2020","unstructured":"Guo, Q. et al. Adiponectin treatment improves insulin resistance in mice by regulating the expression of the mitochondrial-derived peptide MOTS-c and its response to exercise via APPL1-SIRT1-PGC-1alpha. Diabetologia 63 (12), 2675\u20132688 (2020).","journal-title":"Diabetologia"},{"issue":"2","key":"39687_CR31","doi-asserted-by":"publisher","first-page":"130048","DOI":"10.1016\/j.bbagen.2021.130048","volume":"1866","author":"H Kumagai","year":"2022","unstructured":"Kumagai, H. et al. The MOTS-c K14Q polymorphism in the MtDNA is associated with muscle fiber composition and muscular performance. Biochim. Biophys. Acta Gen. Subj. 1866 (2), 130048 (2022).","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"6","key":"39687_CR32","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1093\/humrep\/deac067","volume":"37","author":"P Froment","year":"2022","unstructured":"Froment, P. et al. At the crossroads of fertility and metabolism: the importance of AMPK-dependent signaling in female infertility associated with hyperandrogenism. Hum. Reprod. 37 (6), 1207\u20131228 (2022).","journal-title":"Hum. Reprod."}],"updated-by":[{"DOI":"10.1038\/s41598-026-70401-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39687-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39687-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39687-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:50:47Z","timestamp":1788947447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39687-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39687"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39687-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-70401-z","URL":"https:\/\/doi.org\/10.1038\/s41598-026-70401-z","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"8593"}}